Correlation Between Exelixis and INmune Bio

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Exelixis and INmune Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Exelixis and INmune Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Exelixis and INmune Bio, you can compare the effects of market volatilities on Exelixis and INmune Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Exelixis with a short position of INmune Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Exelixis and INmune Bio.

Diversification Opportunities for Exelixis and INmune Bio

-0.13
  Correlation Coefficient

Good diversification

The 3 months correlation between Exelixis and INmune is -0.13. Overlapping area represents the amount of risk that can be diversified away by holding Exelixis and INmune Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on INmune Bio and Exelixis is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Exelixis are associated (or correlated) with INmune Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of INmune Bio has no effect on the direction of Exelixis i.e., Exelixis and INmune Bio go up and down completely randomly.

Pair Corralation between Exelixis and INmune Bio

Given the investment horizon of 90 days Exelixis is expected to generate 0.82 times more return on investment than INmune Bio. However, Exelixis is 1.22 times less risky than INmune Bio. It trades about 0.36 of its potential returns per unit of risk. INmune Bio is currently generating about -0.3 per unit of risk. If you would invest  2,873  in Exelixis on August 30, 2024 and sell it today you would earn a total of  720.00  from holding Exelixis or generate 25.06% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Exelixis  vs.  INmune Bio

 Performance 
       Timeline  
Exelixis 

Risk-Adjusted Performance

17 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Exelixis are ranked lower than 17 (%) of all global equities and portfolios over the last 90 days. Despite quite weak technical and fundamental indicators, Exelixis disclosed solid returns over the last few months and may actually be approaching a breakup point.
INmune Bio 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days INmune Bio has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's primary indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Exelixis and INmune Bio Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Exelixis and INmune Bio

The main advantage of trading using opposite Exelixis and INmune Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Exelixis position performs unexpectedly, INmune Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in INmune Bio will offset losses from the drop in INmune Bio's long position.
The idea behind Exelixis and INmune Bio pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.

Other Complementary Tools

Fundamental Analysis
View fundamental data based on most recent published financial statements
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio